secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K/A
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001323885-25-000101
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure Q3 revenue $134.3M (+15.8% YoY); net loss narrows to $0.3M; raises FY2025 outlook
--------------------------------------------------------------------------------

- Revenue $134.3M, +15.8% YoY (+15.1% constant currency); US $109.3M (+14.5%), intl $25.0M (+22.0%).
- Net loss $0.3M vs $7.9M loss in Q3 2024; GAAP EPS loss $0.01 vs $0.17; adjusted EBITDA $17.8M (+$9.9M).
- Generated $30.1M cash in Q3, $25.1M YTD; raised full-year 2025 financial outlook.
- Key product drivers: AtriClip FLEX-Mini, EnCompass clamp, cryoSPHERE MAX probe for pain management.
- Gross margin 75.5%, up 59 bps YoY on favorable product mix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/0001323885-25-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/atrc-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001323885-25-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer